Skip to main content
Premium Trial:

Request an Annual Quote

Air Force Cancels ABI Biosecurity Contract

NEW YORK (GenomeWeb News) - The US Department of Defense has terminated a pathogen-identification technology contract with Applied Biosystems because the company and the US Air Force could not agree on the best route for commercializing the product, ABI said Friday. 
 
The DOD awarded ABI a $24.5 million contract last August to develop a prototype system that would identify infectious diseases for epidemiological and biosecurity purposes.
 
ABI said on Friday that it had successfully completed all technical milestones for the contract, but that it was unable to agree with the USAF on “an approach for further development and commercialization of an instrument” based on an ABI prototype.
 
ABI said it anticipates “no material financial impact” from the cancellation of the contract and expects to continue developing pathogen-detection technology for biosecurity applications.
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.